SARS-CoV-2 and Influenza research hub

A phase II, randomized, double-blind, multi-centre trial to evaluate the safety and immunogenicity of BIMERVAX® when coadministered with seasonal surface antigen, inactivated, adjuvanted influenza vaccine (SIIV) in adults older than 65 years of age fully vaccinated against COVID-19.

This study is testing a new COVID-19 vaccine, BIMERVAX®, when given at the same time as a regular flu jab. We want to see if it's safe and how well it helps your body fight off viruses in people over 65.